Novel polypeptides which comprise a receptor-ligand pair involved in T-cellactivation are disclosed. Nucleic acid molecules encoding said polypeptides,and vectors and host cells for expressing same are also disclosed. Thepolypeptides, or agonists and antagonists thereof, are used to treat T-cellmediated disorders.